{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:36:58Z","timestamp":1794490618526,"version":"4.9.1"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis is a chronic immune-mediated inflammatory skin disease, characterized by well-demarcated scaly, erythematous, infiltrated plaques. The cutaneous-to-systemic expansion of the inflammation in psoriasis leads to the concept of \u201cpsoriatic march\u201d or \u201cinflammatory skin march\u201d. Accordingly, psoriasis is thought to be a systemic inflammatory disease associated with numerous comorbidities. Indeed, it\u2019s currently considered an independent risk factor for cardiovascular diseases. Here, we discuss the current knowledge on TNF-\u03b1 and IL-23\/IL-17 mediated pathways linking the psoriatic plaque to the cardiovascular compartment. We further argue the possible involvement of the endothelial compartment in the psoriatic plaque- cardiovascular system crosstalk.<\/jats:p>","DOI":"10.3389\/fimmu.2022.868277","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T06:11:53Z","timestamp":1653372713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Psoriasis and Cardiovascular Diseases: An Immune-Mediated Cross Talk?"],"prefix":"10.3389","volume":"13","author":[{"given":"Gloria","family":"Orlando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Molon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13854","article-title":"A Systematic Review of Worldwide Epidemiology of Psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"a015354","DOI":"10.1101\/cshperspect.a015354","article-title":"Psoriasis","volume":"4","author":"di Meglio","year":"2014","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on Psoriasis Immunopathogenesis and Targeted Immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00766-z","article-title":"Resolution of Plaque-Type Psoriasis: What Is Left Behind (and Reinitiates the Disease)","volume":"41","author":"Benezeder","year":"2019","journal-title":". Semin Immunopathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u2018Psoriatic March\u2019: A Concept of How Severe Psoriasis May Drive Cardiovascular Comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and Comorbid Diseases","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13075-020-2111-8","article-title":"A Set of Serum Markers Detecting Systemic Inflammation in Psoriatic Skin, Entheseal, and Joint Disease in the Absence of C-Reactive Protein and Its Link to Clinical Disease Manifestations","volume":"22","author":"Sokolova","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12255","article-title":"Impact of Systemic Treatment of Psoriasis on Inflammatory Parameters and Markers of Comorbidities and Cardiovascular Risk: Results of a Prospective Longitudinal Observational Study","volume":"28","author":"Montaudi\u00e9","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12257","article-title":"C-Reactive Protein in Psoriasis: A Review of the Literature","volume":"28","author":"Beygi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01095.x","article-title":"Platelet P-Selectin Reflects a State of Cutaneous Inflammation: Possible Application to Monitor Treatment Efficacy in Psoriasis","volume":"19","author":"Garbaraviciene","year":"2009","journal-title":"Exp Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients With Moderate-To-Severe Psoriasis","volume":"132","author":"Su\u00e1rez-Fari\u00f1as","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archdermatol.2011.119","article-title":"Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography \u2013Computed Tomography (Fdg-Pet\/Ct)","volume":"147","author":"Mehta","year":"2011","journal-title":"Arch Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The Association Between Psoriasis and Hypertension","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Hypertens"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26","article-title":"The Association Between Psoriasis and Obesity: A Systematic Review and Meta-Analysis of Observational Studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr Diabetes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12101","article-title":"The Association Between Psoriasis and Dyslipidaemia: A Systematic Review","volume":"168","author":"Ma","year":"2013","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the Risk of Diabetes Mellitus","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Observational Studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12473","article-title":"Psoriasis, Psoriatic Arthritis and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"169","author":"Coto-Segura","year":"2013","journal-title":"Br J Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-Analysis of Psoriasis, Cardiovascular Disease, and Associated Risk Factors","volume":"69","author":"Miller","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","article-title":"Systematic Review and Meta-Analysis of the Association Between Psoriasis and Metabolic Syndrome","volume":"77","author":"Rodr\u00edguez-Z\u00fa\u00f1iga","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181039","article-title":"An Update on Psoriasis and Metabolic Syndrome: A Meta-Analysis of Observational Studies","volume":"12","author":"Singh","year":"2017","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.01.009","article-title":"The Association Between Psoriasis and Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"13","author":"Mamizadeh","year":"2019","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2174\/1871530319666191008170409","article-title":"The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study","volume":"20","author":"Choudhary","year":"2020","journal-title":"Endocr Metab Immune Disord - Drug Targets"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s13205-020-2089-6","article-title":"Psoriasis and Cardiovascular Disorders: Association or Epiphenomenon? Meta-Analysis of Observational Studies","volume":"10","author":"Choudhary","year":"2020","journal-title":"3 Biotech"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14208","article-title":"Pediatric Psoriasis and Association With Cardiovascular and Metabolic Comorbidities: Systematic Review and Meta-Analysis","volume":"37","author":"Phan","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019303","article-title":"A Systematic Review and Meta-Analysis of the Association Between Psoriasis and Hypertension With Adjustment for Covariates","volume":"99","author":"Duan","year":"2020","journal-title":"Medicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5021\/ad.2021.33.3.203","article-title":"Association of Metabolic Comorbidities With Pediatric Psoriasis: A Systematic Review and Meta-Analysis","volume":"33","author":"Cho","year":"2021","journal-title":"Ann Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular Risk in Patients With Psoriasis","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05270.x","article-title":"Association Between Obesity Measured by Different Parameters and Severity of Psoriasis","volume":"52","author":"Duarte","year":"2013","journal-title":"Int J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000455840","article-title":"Psoriasis and Obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/2475530320936373","article-title":"Addressing Hypertension in Patients With Psoriasis: Review and Recommendations","volume":"5","author":"deShazo","year":"2020","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/535612","article-title":"Lipid Disturbances in Psoriasis: An Update","volume":"2010","author":"Pietrzak","year":"2010","journal-title":"Mediat Inflamm"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and Risk of Incident Psoriasis and Psoriatic Arthritis in US Women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of Metabolic Syndrome in Patients With Psoriasis: A Population-Based Study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the Metabolic Syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clinics Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12002","article-title":"Association of Psoriasis With Stroke and Myocardial Infarction: Meta-Analysis of Cohort Studies","volume":"167","author":"Xu","year":"2012","journal-title":"Br J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.01.197","article-title":"Role of Psoriasis as Independent Predictor of Cardiovascular Disease: A Meta-Regression Analysis","volume":"168","author":"Gaeta","year":"2013","journal-title":"Int J Cardiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.07.127","article-title":"Psoriasis and Risk of Cardiovascular Disease: A Meta-Analysis of Cohort Studies","volume":"168","author":"Gu","year":"2013","journal-title":"Int J Cardiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular Morbidity and Mortality in Psoriasis and Psoriatic Arthritis: A Systematic Literature Review","volume":"27","author":"Horreau","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2012.05584.x","article-title":"Cardiovascular Aspects of Psoriasis: An Updated Review","volume":"52","author":"Pietrzak","year":"2013","journal-title":"Int J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.149","article-title":"Incidence of Cardiovascular Disease in Individuals With Psoriasis: A Systematic Review and Meta-Analysis","volume":"133","author":"Samarasekera","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jdv.12162","article-title":"Psoriasis, Cardiovascular Events, Cancer Risk and Alcohol Use: Evidence-Based Recommendations Based on Systematic Review and Expert Opinion","volume":"27","author":"Richard","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1712-1","article-title":"Psoriasis and Cardiovascular Events: Updating the Evidence","volume":"309","author":"Raaby","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.037","article-title":"All-Cause and Cause-Specific Mortality in Psoriasis: A Systematic Review and Meta-Analysis","volume":"80","author":"Dhana","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of Myocardial Infarction in Patients With Psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaad.2017.06.028","article-title":"The Relationship Between Duration of Psoriasis, Vascular Inflammation, and Cardiovascular Events","volume":"77","author":"Egeberg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.05.016","article-title":"The Impact of Psoriasis on 10-Year Framingham Risk","volume":"67","author":"Mehta","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw106","article-title":"European Guidelines on Cardiovascular Disease Prevention in Clinical Practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/Apha\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary","volume":"73","author":"Grundy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Awareness and Attention to Comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.3390\/ijms21197041","article-title":"The Risk of Systemic Diseases in Those With Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic","volume":"21","author":"Woo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01234","article-title":"Potential Immunological Links Between Psoriasis and Cardiovascular Disease","volume":"9","author":"Sajja","year":"2018","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07562.x","article-title":"Psoriasis: A Possible Risk Factor for Development of Coronary Artery Calcification","volume":"156","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","article-title":"Treatment With Tumor Necrosis Factor Inhibitors Restores Coronary Microvascular Function in Young Patients With Severe Psoriasis","volume":"251","author":"Piaserico","year":"2016","journal-title":"Atherosclerosis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.12.015","article-title":"Impaired Coronary Flow Reserve in Young Patients Affected by Severe Psoriasis","volume":"221","author":"Osto","year":"2012","journal-title":"Atherosclerosis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1159\/000182256","article-title":"Chronic Plaque Psoriasis Is Associated With Increased Arterial Stiffness","volume":"218","author":"Gisondi","year":"2009","journal-title":"Dermatology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00446.2017","article-title":"Endothelial Function is Impaired in the Cutaneous Microcirculation of Adults With Psoriasis Through Reductions in Nitric Oxide-Dependent Vasodilation","volume":"314","author":"Alba","year":"2018","journal-title":"Am J Physiology-Heart Circulatory Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714897","article-title":"Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation","volume":"12","author":"Mizuguchi","year":"2021","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","article-title":"The Importance of Endothelin-1 for Vascular Dysfunction in Cardiovascular Disease","volume":"76","author":"Bohm","year":"2007","journal-title":"Cardiovasc Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1038\/s41598-017-14365-1","article-title":"Ifn-\u03b3 and TNF-\u03b1 Synergism May Provide a Link Between Psoriasis and Inflammatory Atherogenesis","volume":"7","author":"Mehta","year":"2017","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01308.x","article-title":"A Tale of Two Plaques: Convergent Mechanisms of T-Cell-Mediated Inflammation in Psoriasis and Atherosclerosis","volume":"20","author":"Armstrong","year":"2011","journal-title":"Exp Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03096","article-title":"Il-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"von Stebut","year":"2020","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its Target Genes: Mechanisms of Interleukin-17 Function in Disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.227629","article-title":"Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E\u2013Deficient Mice","volume":"31","author":"Madhur","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1159\/000317400","article-title":"Pro-Inflammatory Effects of Interleukin-17A on Vascular Smooth Muscle Cells Involve Nad(P)H- Oxidase Derived Reactive Oxygen Species","volume":"48","author":"Pietrowski","year":"2011","journal-title":"J Vasc Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.02.026","article-title":"Revisiting Pharmacology of Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Evidence for Redox-Based Therapies","author":"Daiber","year":"2020","journal-title":"Free Radical Biol Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.020719","article-title":"TNF Therapy in Psoriatic Arthritis and Psoriasis","volume":"63","author":"Mease","year":"2004","journal-title":"Ann Rheumatic Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031740","article-title":"Immunopathology of Psoriasis and Psoriatic Arthritis","volume":"64","author":"Veale","year":"2005","journal-title":"Ann Rheumatic Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 Are Coexpressed by Th17 Cells and Cooperatively Enhance Expression of Antimicrobial Peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902464","article-title":"Skin Inflammation Induced by the Synergistic Action of IL-17a, Il-22, Oncostatin M, Il-1\u03b1, and TNF-\u03b1 Recapitulates Some Features of Psoriasis","volume":"184","author":"Guilloteau","year":"2010","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.774808","article-title":"Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis","volume":"12","author":"Cai","year":"2021","journal-title":"Front Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01668","article-title":"Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows","volume":"9","author":"Caiazzo","year":"2018","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11883-021-00963-y","article-title":"Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics","volume":"23","author":"Weber","year":"2021","journal-title":"Curr Atheroscl Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.4091","article-title":"Op0229\u2005the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (Grappa) Treatment Recommendations 2021","volume":"80","author":"Coates","year":"2021","journal-title":"Ann Rheumatic Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR Recommendations for Cardiovascular Disease Risk Management in Patients With Rheumatoid Arthritis and Other Forms of Inflammatory Joint Disorders: 2015\/2016 Update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheumatic Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2796.2012.02593.x","article-title":"Cardiovascular Disease Event Rates in Patients With Severe Psoriasis Treated With Systemic Anti-Inflammatory Drugs: A Danish Real-World Cohort Study","volume":"273","author":"Ahlehoff","year":"2013","journal-title":"J Internal Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate Reduces Incidence of Vascular Diseases in Veterans With Psoriasis or Rheumatoid Arthritis","volume":"52","author":"Prodanowich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/ijms18102211","article-title":"Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment","volume":"18","author":"Hu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03947.x","article-title":"Effective Continuous Systemic Therapy of Severe Plaque-Type Psoriasis is Accompanied by Amelioration of Biomarkers of Cardiovascular Risk: Results of a Prospective Longitudinal Observational Study","volume":"25","author":"Boehncke","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007394","article-title":"Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers","volume":"11","author":"Mehta","year":"2018","journal-title":"Circulation: Cardiovasc Imaging"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamacardio.2017.1213","article-title":"Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis","volume":"2","author":"Dey","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13398","article-title":"Anti-Tumor Necrosis Factor-Alpha Therapy Improves Endothelial Function and Arterial Stiffness in Patients With Moderate to Severe Psoriasis: A 6-Month Prospective Study","volume":"43","author":"Pina","year":"2016","journal-title":"J Dermatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz009","article-title":"Coronary Artery Plaque Characteristics and Treatment With Biologic Therapy in Severe Psoriasis: Results From a Prospective Observational Study","volume":"115","author":"Elnabawi","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13152","article-title":"Myocardial Function and Effects of Biologic Therapy in Patients With Severe Psoriasis: A Prospective Echocardiographic Study","volume":"30","author":"Ahlehoff","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13649","article-title":"Subclinical Cardiovascular Disease and It\u2019s Improvement After Long-Term TNF-\u03b1 Inhibitor Therapy in Severe Psoriatic Patients","volume":"30","author":"Her\u00e9di","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8560-9","article-title":"The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: An Updated Meta-Analysis","volume":"51","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/archdermatol.2012.2502","article-title":"Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis","volume":"148","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.050","article-title":"The Risk of Cardiovascular Events in Psoriasis Patients Treated With Tumor Necrosis Factor\u2013\u03b1 Inhibitors Versus Phototherapy: An Observational Cohort Study","volume":"79","author":"Wu","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaad.2016.07.042","article-title":"Cardiovascular Event Risk Assessment in Psoriasis Patients Treated With Tumor Necrosis Factor-\u03b1 Inhibitors Versus Methotrexate","volume":"76","author":"Wu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.021","article-title":"Antagonization of IL-17a Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis","volume":"139","author":"Sch\u00fcler","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients Over 52 Weeks","volume":"139","author":"von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jid.2020.01.025","article-title":"A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-To-Severe Plaque Psoriasis (Vip-S)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10257.x","article-title":"Cardiovascular Safety of Ustekinumab in Patients With Moderate to Severe Psoriasis: Results of Integrated Analyses of Data From Phase II and III Clinical Studies","volume":"164","author":"Reich","year":"2011","journal-title":"Br J Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1211","article-title":"Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events","volume":"306","author":"Ryan","year":"2011","journal-title":"JAMA"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.jid.2021.03.024","article-title":"Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients With Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials","volume":"141","author":"Gonz\u00e1lez-Cantero","year":"2021","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.868277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T06:11:56Z","timestamp":1653372716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.868277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":101,"alternative-id":["10.3389\/fimmu.2022.868277"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.868277","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"article-number":"868277"}}